
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Generated by Workzil AI
Lycia Therapeutics is a Biotechnology company.
More about Lycia Therapeutics
Employees
10-50
Founded
N/A
Funding
Undisclosed
Status
Private
Remote Policy
Office only
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Get hiring trends, funding, and news on Lycia Therapeutics in your inbox.
We'll email you the moment Lycia Therapeutics posts a new role.